European Commission to Simplify the Procedures for Taking Part in EU-funded Research Projects

The overall aim is to make participation transparent and attractive to the best researchers and innovative companies in Europe and beyond. Ensuring European research realises its full potential is crucial to the EU's Europe 2020 Strategy, given the need to consolidate economic recovery and develop new sources of growth and jobs to replace those lost in the crisis. Complementing the proposals on simplification, the Commission has also appointed a group of independent experts to review all aspects of the current Seventh Framework Programme.

Research, Innovation and Science Commissioner Máire Geoghegan-Quinn said: "Our proposals aim to minimise administrative burdens in Europe's research programmes. We need to get the best researchers and most innovative companies taking part and we need to enable them to concentrate on results, not red tape. That will boost Europe's economy and quality of life. In particular, we must encourage more SME's to join in. I believe this can be done without compromising financial control. We are asking the other EU institutions for support to achieve this."

Budget Commissioner Janusz Lewandowski added: "The review of the Financial regulation which the Commission will present next month will underpin these ideas for simplifying research funding with concrete legal proposals, helpful also in many other policy areas. We need simpler rules to encourage potential beneficiaries of EU funds - such as small and medium enterprises or NGOs - to apply for them. Simplification means the EU budget serving citizens and businesses better."

The first part of the Commission's strategy will make improvements possible under the current legal and regulatory framework, some of which are already underway. These involve, for example, better IT systems, more consistent application of rules, in particular on auditing, and improving the structure and content of the "calls for proposals" in response to which research organisations bid for funding.

The second part involves changing the existing financial rules to allow more radical simplification while maintaining effective control, for example by widening the use of "average cost methodologies" that avoid the need for projects to account separately and painstakingly for each small item of expenditure. The Commission also aims to allow projects to use the same accounting methods for EU funding as they are required to use for national research funding. These proposals require a decision of the European Parliament and the Council.

The third type of change envisaged will be considered for implementation under future Research Framework Programmes. Among the options presented is a move towards "payment by results", which would mean that beneficiaries were paid lump sums to undertake specific scientific tasks and would need to demonstrate that they have done so effectively and efficiently, rather than to report individual cost items.

In the meantime, the Commission has launched the interim evaluation of the current Programme (FP7). A group of independent experts, chaired by Mr. Rolf Annerberg, has been appointed to undertake this review and present their report this autumn.

Mr Annerberg is Director General of the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas). The mandate of the group covers a wide range of issues related to the design, implementation and impact of Framework Programme activities.

Background
FP7 has proved very attractive to the research community with more than 33,000 proposals received since 2007, almost 7000 projects funded. Nearly all European universities participate.

Several concrete steps have already been taken towards simplification of procedures both in setting up FP 7 and since it has been in progress.

For example, FP7 introduced a new Guarantee Fund and a single registration facility meaning organisations applying for funding for several projects over several years need only enter their details once. Eight out of ten participants in FP7 are now exempt from ex-ante financial capacity checks and three out of four participants are exempt from providing certificates on financial statements needed for periodic cost claims.

Two new Executive Agencies were set up by the Commission in 2007: the Research Executive Agency (REA) and the European Research Council Executive Agency (ERC-EA). The European Research Council is a flagship component of FP 7 and awards grants to projects headed by starting and established researchers, with no requirement for projects to involve cross-border consortia.

For further information, please visit:
http://ec.europa.eu/research/fp7/index_en.cfm?pg=documents

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Powerful New AI can Predict People'…

A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...